GlaxoSmithKline Settles First Zantac Cancer Lawsuit
GlaxoSmithKline (GSK), a British pharmaceutical giant, has reached a confidential settlement in the first Zantac cancer lawsuit, averting a trial in a California state court. The plaintiff claimed that GSK's heartburn medication Zantac caused his cancer, joining more than 70,000 lawsuits filed against GSK and other pharmaceutical … [Read more...] about GlaxoSmithKline Settles First Zantac Cancer Lawsuit
Sanofi Allegedly Destroyed Emails Concerning the Zantac Recall
A news report on blumberg.com states that French drug manufacturer Sanofi allegedly destroyed company emails that were connected to a 2019 recall of the company’s heartburn medication Zantac. The allegations come from plaintiffs' attorneys who are representing 70,000 former users of Zantac who have filed a lawsuit against the company … [Read more...] about Sanofi Allegedly Destroyed Emails Concerning the Zantac Recall
FDA Says that Drug Makers Must Stop Ranitidine Sales
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) told drug makers who sell ranitidine-based medications to stop. Ranitidine is the generic name for the active ingredient in acid-reducing drugs like Zantac. Zantac is known as the most-prescribed drug across the globe in 1987, according to Wired. Now the FDA has asked … [Read more...] about FDA Says that Drug Makers Must Stop Ranitidine Sales
Zantac Still Being Sold in US
USA- dailymail.co.uk writes that while other countries are removing Zantac from their drug stores, the heartburn medication can still be found in pharmacies in the United States. In Europe, four prescription varieties of the drug were subject to recalls. The generic variety, as well as the brand name versions of the drug, were found … [Read more...] about Zantac Still Being Sold in US
Generic Zantac Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration will work with drug manufacturing companies to recall generic versions of Zantac because of the presence of a potentially cancer-causing agent located in the medication. The U.S. FDA said that potentially cancer-causing agent in Zantac is n-nitrosodimethylamine or NDMA for … [Read more...] about Generic Zantac Cancer
FDA Warns of Carcinogen Lurking in Zantac
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) released a statement discussing the potential dangers users of ranitidine medications face. Ranitidine, the generic version of the anti-heartburn medication Zantac, may contain a potentially carcinogenic chemical according to the latest statement announced by the FDA. The … [Read more...] about FDA Warns of Carcinogen Lurking in Zantac
